| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 04/13/2006 | US20060079578 Comprises 3-amino-1-propanesulfonic acid for reducing/preventing gastrointestinal intolerance; treating Alzheimer's disease, cerebral amyloid angiopathy, inclusion body myositis, macular degeneration, Down's syndrome, mild cognitive impairment, and hereditary cerebral hemorrhage; side effects reduction |
| 04/13/2006 | US20060079539 Synergistic combination |
| 04/13/2006 | US20060079516 Highly concentrated stable meloxicam solutions |
| 04/13/2006 | US20060079502 Pharmaceutical compositions |
| 04/13/2006 | US20060079496 Agglomerates by crystallisation |
| 04/13/2006 | US20060079489 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine |
| 04/13/2006 | US20060079460 Purified LH |
| 04/13/2006 | US20060079455 Peptide nanostructures encapsulating a foreign material and method of manufacturing same |
| 04/13/2006 | US20060079453 Hla binding peptides and their uses |
| 04/13/2006 | US20060079450 Polypeptide that does not include an N-linked glycosylation site such as interleukin-11 stabilized with hydroxyethyl starch and a disaccharide such as trehalose and sucrose; stable for at least 9 months when stored at 60 degrees C. |
| 04/13/2006 | US20060078705 Carbon nanotube fiber-reinforced composite structures for EM and lightning strike protection |
| 04/13/2006 | US20060078626 Opthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 04/13/2006 | US20060078624 Microparticles and nanoparticles containing a lipopolymer |
| 04/13/2006 | US20060078623 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
| 04/13/2006 | US20060078622 Pharmaceutical formulations containing microparticles or nanoparticles of a delivery agent |
| 04/13/2006 | US20060078621 Method of providing customized drug delivery systems |
| 04/13/2006 | US20060078620 Oil composition based on peroxidised lipids, which can be used in the treatment of xerostomia |
| 04/13/2006 | US20060078619 Method for the preparatin of paclitaxel solid dispersion by using the supercritical fluid process and paclitaxel solid dispersion prepared thereby |
| 04/13/2006 | US20060078618 Lipid particles and suspensions and uses thereof |
| 04/13/2006 | US20060078617 Pharmaceutical compositions for the treatment of cancer |
| 04/13/2006 | US20060078616 Thermoreversible pharmaceutical formulation for anti-microbial agents comprising poloxamer polymers and hydroxy fatty acid ester of polyethylene glycol |
| 04/13/2006 | US20060078615 Bilayer tablet of telmisartan and simvastatin |
| 04/13/2006 | US20060078614 Taste-masked pharmaceutical compositions |
| 04/13/2006 | US20060078613 Compositions and methods for minimizing adverse drug experiences associated with oxybutynin therapy |
| 04/13/2006 | US20060078612 Chewable enteric coated aspirin tablets |
| 04/13/2006 | US20060078611 Enteric coated aspirin granules comingled with binder |
| 04/13/2006 | US20060078610 Method for producing pharmaceuticals or food supplements comprising pigmented polymer coatings |
| 04/13/2006 | US20060078609 Pharmaceutical compositions comprising a basic respectively acidic drug compound, a surfactant and a physiologically tolerable water soluble and respectively base |
| 04/13/2006 | US20060078608 Flavored gelatin capsule and method for producing said capsule |
| 04/13/2006 | US20060078607 Liposome formulation of 6,9-bis[(2-aminoethyl)-amino]benzo[g]isoquinoline-5, 10-dione dimaleate |
| 04/13/2006 | US20060078606 Sustained-release liposomal anesthetic compositions |
| 04/13/2006 | US20060078605 Pharmaceutical composition of small-sized liposomes and method of preparation |
| 04/13/2006 | US20060078604 Transdermal drug delivery device including an occlusive backing |
| 04/13/2006 | US20060078603 Transdermal delivery of drugs based on crystal size |
| 04/13/2006 | US20060078602 Device for transdermal administration of drugs including acrylic polymers |
| 04/13/2006 | US20060078601 Compositions and methods for delivering estradiol in transdermal drug delivery systems |
| 04/13/2006 | US20060078600 Transdermal therapeutic system suitable for heat application for promoting the permeation of active substances, and the use thereof |
| 04/13/2006 | US20060078597 Ascorbic acid salt suspensions and use thereof as antioxidants |
| 04/13/2006 | US20060078575 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 04/13/2006 | US20060078574 Purified phospholipid-non-steroidal anti-inflammatory drug associated compositions and methods for preparing and using same |
| 04/13/2006 | US20060078573 Methods of modifying crystal habit |
| 04/13/2006 | US20060078547 Lactobacillus salivarius strain, AH102, AH103, AH105, AH109 or AH110 or mutants or variants are useful in the prophylaxis and/or treatment undesirable gastrointestinal inflammatory activity, such as inflammatory bowel disease or irritable bowel syndrome |
| 04/13/2006 | US20060078542 Gel-based delivery of recombinant adeno-associated virus vectors |
| 04/13/2006 | US20060078516 Sunless tanning system |
| 04/13/2006 | US20060078515 Sunscreen wipes |
| 04/13/2006 | US20060078509 Effervescent pressed gum tablet compositions |
| 04/13/2006 | US20060078508 Effervescent pressed gum tablet compositions |
| 04/13/2006 | US20060078506 Methods, systems and devices for noninvasive pulmonary delivery |
| 04/13/2006 | US20060078504 Sustanined-release pharmaceutical composition for lung administration |
| 04/13/2006 | US20060078496 Method of drug delivery to interstitial regions of the myocardium |
| 04/13/2006 | US20060076011 Methods and apparatus for the enhanced delivery of physiologic agents to tissue surfaces |
| 04/13/2006 | US20060075927 Aqueous shellac coating agent and production process therefor, and coated food and production process therefor, coated drug and production process therefor, glazing composition for oil-based confectionary, glazing process, and glazed oil-based confectionary using same |
| 04/13/2006 | DE4341113B4 Stabile multiple X/O/Y-Emulsion Stable multiple X / O / Y emulsion |
| 04/13/2006 | DE102004050457A1 Segmentierte Vorrichtung für die verzögerte Freisetzung von Molekülen in tangentialer Richtung durch dünne Filme und Anwendungen derselben Segmented device for the sustained release of molecules in a tangential direction through thin films and applications thereof |
| 04/13/2006 | DE102004046355A1 New polyethylene glycol compound useful e.g. as solvents for active substances, flavorants or odorants in medical drops, injection solutions, food auxiliary agents, tablets, ointments, sticks or gelatin capsules and softener |
| 04/13/2006 | CA2582974A1 Cosmetic neurotoxin compositions comprising a botulinum toxin component and methods |
| 04/13/2006 | CA2582949A1 Liposomes with improved drug retention for treatment of cancer |
| 04/13/2006 | CA2582937A1 Formulation of multivalent antibody constructs and use of same for cancer therapy |
| 04/13/2006 | CA2582668A1 Nanoparticles comprising antigens and adjuvants, and immunogenic structures |
| 04/13/2006 | CA2582568A1 Device for producing a medicinal foam |
| 04/13/2006 | CA2582474A1 Wound dressing compositions, especially for delivery of protease inhibitors |
| 04/13/2006 | CA2582420A1 Methods and kits for delivering drugs by nebulisation |
| 04/13/2006 | CA2582405A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 04/13/2006 | CA2582403A1 Pharmaceutical compositions comprising fenofibrate and atorvastatin |
| 04/13/2006 | CA2582373A1 Technical specification editor |
| 04/13/2006 | CA2582300A1 Oral pharmaceutical preparation comprising a proton pump antagonist and a basic excipient |
| 04/13/2006 | CA2582299A1 Oral pharmaceutical preparation for proton pump antagonists |
| 04/13/2006 | CA2582150A1 Modified release ibuprofen dosage form |
| 04/13/2006 | CA2582096A1 Conveniently implantable sustained release drug compositions |
| 04/13/2006 | CA2581373A1 Sealed, edible film strip packets and methods of making and using them |
| 04/13/2006 | CA2581282A1 Solid pharmaceutical preparation |
| 04/13/2006 | CA2581196A1 Modifying surfaces of lactose serving as an auxiliary agent to be used for powder inhalants |
| 04/13/2006 | CA2581190A1 Microparticles and nanoparticles containing a lipopolymer |
| 04/13/2006 | CA2581169A1 Pharmaceutical dosage forms of stable amorphous rapamycin like compounds |
| 04/13/2006 | CA2581051A1 Pulmonary administration of an antithrombotic compound |
| 04/13/2006 | CA2580529A1 Fine particle-containing composition and manufacturing method therefor |
| 04/13/2006 | CA2580525A1 Lercanidipine capsules |
| 04/13/2006 | CA2578449A1 Novel powder inhalation preparations based on modified lactose blends that are used as adjuvants |
| 04/12/2006 | EP1645597A1 Conjugate of fine porous particles with polymer molecules and utilization thereof |
| 04/12/2006 | EP1645287A2 Anhydrous topical skin preparations |
| 04/12/2006 | EP1645282A1 Use of fibrinolytic metalloproteinases for treating blood clots |
| 04/12/2006 | EP1645277A1 Stable tetrodotoxin freeze drying medicinal preparation |
| 04/12/2006 | EP1645269A1 Method and apparatus for the production of nanoparticles and microparticles and the use of said particles |
| 04/12/2006 | EP1645268A1 Hard capsule |
| 04/12/2006 | EP1645267A2 Method for producing an active ingredient concentrate and active ingredient concentrate |
| 04/12/2006 | EP1645266A1 Aqueous suspension for nasal drops |
| 04/12/2006 | EP1645243A2 Implantable device |
| 04/12/2006 | EP1644128A2 Moving emanators |
| 04/12/2006 | EP1644057A2 Drug delivery device and syringe for filling the same |
| 04/12/2006 | EP1644047A2 Delivery of a drug via subconjuctival or periocular delivery of a prodrug in a polymeric microparticle |
| 04/12/2006 | EP1644010A2 Colloidal silver composition having antimicrobial properties |
| 04/12/2006 | EP1644002A1 Multiparticulates |
| 04/12/2006 | EP1643982A2 Method of treating acute myocardial infarction |
| 04/12/2006 | EP1643980A1 Dry powder for inhalation comprising a formoterol salt and ciclesonide |
| 04/12/2006 | EP1643979A1 Pharmaceutical aerosol composition |
| 04/12/2006 | EP1643978A1 Parathyroid hormone (pth) containing pharmaceutical compositions for oral use |
| 04/12/2006 | EP1643977A2 Multiparticle pharmaceutical dosage form containing a mucoadhesively formulated peptide or protein active substances method for producing said pharmaceutical dosage form |
| 04/12/2006 | EP1643976A2 Pharmaceutical formulation comprising levothyroxine sodium |
| 04/12/2006 | EP1643975A2 Process for preparing formulations of lipid-regulating drugs |
| 04/12/2006 | EP1643974A1 Inhalable pharmaceutical formulations comprising a sugar ester |